Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Cancers
|
May 4, 2026
Clinical Outcomes of Peptide Receptor Radionuclide Therapy in Japanese Patients with Metastatic Rectal Neuroendocrine Tumors
Takeshi Iizuka, Noritoshi Kobayashi, Damian Wild, et al.
RMD Open
|
August 1, 2020
Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction
Yoshiya Tanaka, Satoshi Soen, Naoki Ishiguro, et al.
Molecular and Clinical Oncology
|
October 18, 2024
Potential neuroendocrine differentiation in poorly differentiated colorectal adenocarcinoma: A hidden trait?
Yuhan Rong, Ikuma Kato, Naoki Okubo, et al.
Scientific Reports
|
July 17, 2019
REV-ERBα and REV-ERBβ function as key factors regulating Mammalian Circadian Output
Ryosuke Ikeda, Yoshiki Tsuchiya, Nobuya Koike, et al.
Scientific Reports
|
November 13, 2025
Treatment of initially unresectable local advanced pancreatic adenocarcinoma with FOLFIRINOX: A prospective study YCOG1403 (C-FLAP study)
Noritoshi Kobayashi, Yasuhiro Yabushita, Ryutaro Mori, et al.
Frontiers in Physiology
|
December 1, 2025
Chronic circadian misalignment accelerates sarcopenia progression in mice
Takashi Seya, Nobuya Koike, Naoki Okubo, et al.
Annals of the Rheumatic Diseases
|
September 15, 2022
Targeting FoxO transcription factors with HDAC inhibitors for the treatment of osteoarthritis
Hiroki Ohzono, Yiwen Hu, Keita Nagira, et al.
Annals of Nuclear Medicine
|
September 17, 2021
Safety and efficacy of peptide receptor radionuclide therapy with <sup>177</sup>Lu-DOTA<sup>0</sup>-Tyr<sup>3</sup>-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors
Noritoshi Kobayashi, Shoko Takano, Kenichi Ito, et al.
Frontiers in Oncology
|
October 26, 2020
Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype
Takaomi Kessoku, Noritoshi Kobayashi, Masato Yoneda, et al.
The Oncologist
|
June 28, 2021
Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake
Anna Ozaki, Takaomi Kessoku, Yuki Kasai, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Cancers
|
May 4, 2026
Clinical Outcomes of Peptide Receptor Radionuclide Therapy in Japanese Patients with Metastatic Rectal Neuroendocrine Tumors
Takeshi Iizuka, Noritoshi Kobayashi, Damian Wild, et al.
RMD Open
|
August 1, 2020
Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction
Yoshiya Tanaka, Satoshi Soen, Naoki Ishiguro, et al.
Molecular and Clinical Oncology
|
October 18, 2024
Potential neuroendocrine differentiation in poorly differentiated colorectal adenocarcinoma: A hidden trait?
Yuhan Rong, Ikuma Kato, Naoki Okubo, et al.
Scientific Reports
|
July 17, 2019
REV-ERBα and REV-ERBβ function as key factors regulating Mammalian Circadian Output
Ryosuke Ikeda, Yoshiki Tsuchiya, Nobuya Koike, et al.
Scientific Reports
|
November 13, 2025
Treatment of initially unresectable local advanced pancreatic adenocarcinoma with FOLFIRINOX: A prospective study YCOG1403 (C-FLAP study)
Noritoshi Kobayashi, Yasuhiro Yabushita, Ryutaro Mori, et al.
Frontiers in Physiology
|
December 1, 2025
Chronic circadian misalignment accelerates sarcopenia progression in mice
Takashi Seya, Nobuya Koike, Naoki Okubo, et al.
Annals of the Rheumatic Diseases
|
September 15, 2022
Targeting FoxO transcription factors with HDAC inhibitors for the treatment of osteoarthritis
Hiroki Ohzono, Yiwen Hu, Keita Nagira, et al.
Annals of Nuclear Medicine
|
September 17, 2021
Safety and efficacy of peptide receptor radionuclide therapy with <sup>177</sup>Lu-DOTA<sup>0</sup>-Tyr<sup>3</sup>-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors
Noritoshi Kobayashi, Shoko Takano, Kenichi Ito, et al.
Frontiers in Oncology
|
October 26, 2020
Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype
Takaomi Kessoku, Noritoshi Kobayashi, Masato Yoneda, et al.
The Oncologist
|
June 28, 2021
Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake
Anna Ozaki, Takaomi Kessoku, Yuki Kasai, et al.
Page
of 7